• Abstracts must be written in English using the “NCIASP 2025 abstract template” (Please click here to download the word template). Please see more criteria and information on the NCIASP 2025 website.
• The deadline for abstract submission is 31 July 2025.

• Addictions to Psychotropic Substances
• Addictions, Gambling and Internet abuse
• ADHD
• Adversity and Psychiatry
• Anxiety Disorders
• Art and Psychiatry
• Autism Spectrum Disorders
• Bipolar Disorders
• Child and Adolescent Psychiatry (including Infant Psychiatry)
• Classification, Diagnostic Assessment and Nomenclature
• Comorbidity of Mental and Somatic Disorders
• Consultation Liaison Psychiatry
• COVID-19
• Dementia/Neurocognitive disorders
• Developmental Psychopathology
• Digital Psychiatry
• Early Interventions in Psychiatry
• Eating Disorders
• Emergency Psychiatry
• Epidemiology in Psychiatry
• Ethical Issues in Psychiatry
• First Episode Psychosis
• Gender and Mental Health
• Human Rights and Mental Health
• Mental Health and Public Health
• Mental Health Care Act, 2017
• Mental Health Economics
• Mental Health Users and Care Givers
• Mood Disorders and other depression and anxiety
• Neurological-Psychiatric syndromes
• Neuromodulation (including DBS, TMS; tDCS, VNS; Neurofeedback)
• Neuroscience and psychiatry, Neuro-imaging
• Neurodevelopmental disorders
• NGOs in Public Mental Health Obsessive-compulsive disorders
• Old Age Psychiatry
• Perinatal Disorders
• Psychiatric Nursing
• Psychiatric Social Work: Challenges Psychology and Public Mental Health
• Advances in Psychological testing
• Psychiatry in Developing Countries
• Psychopharmacology
• Psychotherapies
• Rehabilitation of People with Mental Disorders
• Religion, Spirituality and Psychiatry
• Schizophrenia and Psychotic Spectrum Disorders Sleep Wakefulness Disorders
• Somatic Treatments other than Pharmacotherapy
• Stigma and Mental Illness
• Suicidology
• Telepsychiatry
• Urban Mental Health
• Religion, Spirituality and Psychiatry
• Schizophrenia and Psychotic Spectrum Disorders
• Sleep Wakefulness Disorders
• Somatic Treatments other than Pharmacotherapy
• Stigma and Mental Illness
• Suicidology
• Telepsychiatry
• Urban Mental Health
• Youth Mental Health
• Others (Not covered in above topics)

• A descriptive title, list of authors (in the desired order) and institutions;
• An introduction / rationale to the study;
• The material and methods used;
• The results of the study including new data not previously published or presented at a major national or international meeting;

• Introduction/ Rationale,
• Material and Methods,
• Results and Conclusions.

• Abstracts of only registered delegates will be considered for reviewing.

• The abstract must be submitted in English, font ‘Times New Roman’ and size 12. If accepted, the subsequent presentation would be in English only.

• Each abstract should have a distinctive hypothesis or include a unique methodology that is clearly differentiated from the other abstracts submitted by a single research group.
• An abstract that fails to meet these criteria will be considered a duplicate.
• Duplicate abstracts from a single research group will be rejected.
• In case submitted multiple times, only the latest one will be considered.

• All abstracts must specify the funding source.
• Compliance to this rule is a prerequisite for review. Abstracts of research funded by tobacco industry sources (whole or in part) will not be considered. If you have no specific funding source, please indicate "none." ??

• It is required that all authors listed on the abstract have knowledge of the abstract submission.

• The total word count of an abstract may not exceed 400 words (not including title, authors' information, institutions, tables, images and spaces between words).

• You can include up to 1 table OR 1 image.

• No corrections will be allowed after submitting the abstract. Please proof-read and edit your abstract carefully before submission.
• If you wish to withdraw your submitted abstract after the abstract submission deadline, please email to conference secretariat at info@nciasp2025.org .

• Abstracts must meet acceptable scientific and ethical standards, and contain data not previously published or presented.
• You are allowed to state your presentation preference, however the Organizing Committee will decide on the presentation format of all accepted abstracts (oral or poster).
• NCIASP 2025 Organizing Committee reserves the final decision for all submitted abstracts.
• All submissions shall go through an extensive peer review process through a preselected peer review committee.
• Peer review may be blinded with adequate safeguards regarding conflict of interest.

• The person assigned as the Presenting Author of accepted abstracts will be expected to present the study. If the Presenting Author is not available, a co- author is allowed to present the paper (subject to the Organizing Committee’s approval) after conference registration and prior notice six weeks before the conference.
• Presenting author must be registered for the conference.
• Authors scheduled for a poster presentation will be assigned poster board space bearing a specific ID for a specified period.
• Oral presenters will present a short PowerPoint presentation, followed by discussion.
• Those abstracts selected for short talk session will be given a short presentation.
• The abstracts selected for presentation should be represented on podium. Failure to do, without valid reason, will disqualify the presenter and group for subsequent two conferences.
• The abstracts will be published in Journal and the authors have to give consent including the copyright transfer for the same while submitting the abstract.

• Notification of abstract acceptance or rejection will be sent electronically to the Presenting Author as per the deadlines stated in the important dates at the email address provided in the online submission. It is the responsibility of the Presenting Author to ensure that the email address is correct.

Should you need any further information / clarification, please contact the secretariat at info@nciasp2025.org.